Page last updated: 2024-08-23

5-methoxy-alpha-methyltryptamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

5-methoxy-alpha-methyltryptamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies

*4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist [MeSH]

*4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HH; Lynch, VM; May, JA; McLaughlin, MA; Rusinko, A; Sharif, NA1

Other Studies

1 other study(ies) available for 5-methoxy-alpha-methyltryptamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

ArticleYear
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Administration, Topical; Animals; Antihypertensive Agents; Blood Pressure; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Indoles; Inhibitory Concentration 50; Macaca fascicularis; Models, Molecular; Ocular Hypertension; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Stereoisomerism

2003